Explore 3 Stock Ideas & Industry Insights Download Free Report

News

Why Did Vivakor (NASDAQ:VIVK) Leap 33.24% With No Clear Catalyst in Sight?

Vivakor operates inCrude Oilgathering, storage and transportation, along with contaminated soil remediation. The second-quarter 2026 report showed revenue of USD 32.1 million, up from USD 29.1 million, and a net loss of USD 2.8 million against USD 12.5 million a year earlier. Six-month revenue …

Vinay Lochav | 06 November 2026

Can Onconetix (NASDAQ:ONCO) Hold a 32.24% Pop While Its Realbotix Deal Stays Pending?

The story behind the stock is its pending purchase of Realbotix, a maker of AI-powered humanoid robots. Onconetix signed a definitive share exchange agreement in mid-February 2026 to acquire 100% of Realbotix in an all-stock deal. Realbotix holders are expected to own a large …

Vinay Lochav | 06 November 2026

Is the 32.23% Jump at Helport AI (NASDAQ:HPAI) a Rebound or a Reprieve?

On November 3, 2026 the company filed a notice that its annual report on Form 20-F for the fiscal year ended June 30, 2026 could not be filed on time. It expects to file within 15 calendar days after the original due date. The …

Vinay Lochav | 06 November 2026

Why Is Kodiak AI (NASDAQ:KDK) Up 30.9% After Revenue Rose 286% to USD 2.97 Million?

HeadlineNet Incomeof USD 27.4 million, or USD 0.09 per diluted share, is not an operating profit. It was driven mainly by a USD 78.2 million non-cash gain from the change inFair Valueof common stock warrants, while the third quarter of 2025 showed a net …

Vinay Lochav | 06 November 2026

Can Serve Robotics (NASDAQ:SERV) Hold a 30.39% Jump as 2026 Revenue Outlook Hits USD 12 Million?

TheBusinessis still deeply unprofitable. Gross loss was USD 7.555 million on cost of revenues of USD 10.39 million, and the GAAP net loss was USD 59.23 million, or USD 0.68 a share. Adjusted EBITDA loss narrowed to USD 42.182 million from USD 44.471 million …

Vinay Lochav | 06 November 2026

What Lifted Obsidian Therapeutics (NASDAQ:OBX) 30.21% When It Sits Near a 52-Week Low?

Obsidian develops engineered tumor-infiltrating lymphocyte cell therapies for solid tumors. Its lead candidate, OBX-115, is in a Phase 2 study in advanced melanoma and a Phase 1 study in non-small cell lung cancer. The merger with Galera Therapeutics closed in early August 2026 alongside …

Vinay Lochav | 06 November 2026

How Did Clean Energy Fuels (NASDAQ:CLNE) Surge 30.13% After Lifting Its 2026 EBITDA Outlook?

Policy support played a large part. The company recognized USD 12.7 million of Section 45Z production tax credits in cost of sales, plus USD 9.2 million withinEquitymethod income. It closed a USD 30.7 million sale of federal tax credits, including a USD 26.0 million …

Vinay Lochav | 06 November 2026

Can VisionSys AI (NASDAQ:VSA) Hold a 29.55% Jump When No Company Announcement Explains It?

The most recent verified corporate action is a one-for-ten reverse split of the American depositary shares, effective May 26, 2026. The Class A shares themselves were unchanged, but each depositary share now represents 2,500 of them instead of 250, so any price history before …

Vinay Lochav | 06 November 2026

Is a First Positive EBITDA Quarter Behind the 29.16% Surge in Blink Charging (NASDAQ:BLNK)?

Revenue of USD 18.4 million missed the company's own projections, which it attributed to project timing. The net loss widened to USD 6.7 million, or USD 0.05 a share, from USD 0.3 million, although the year-earlier quarter included an USD 11.7 million non-cashFair Valuegain. …

Vinay Lochav | 06 November 2026

How Did Karman Space & Defense (NYSE:KRMN) Jump 29.01% on a USD 201.6 Million Quarter?

The company supplies subsystems for missile, hypersonic, space and maritime defense programs. Tactical Missiles and Integrated Defense Systems revenue rose 51.9% to USD 67.6 million, and Hypersonics and Strategic Missile Defense rose 39.6% to USD 51.1 million. Maritime Defense Systems, a new reporting line, …

Vinay Lochav | 06 November 2026
Support

Hi! How can we help you today?

Loading…